NESHER PHARMS
GenericsNESHER PHARMS is a generic drug manufacturer focused on Cardiovascular, Infectious Disease.
NESHER PHARMS's Key Drugs
NESHER PHARMS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
NESHER PHARMS's Recent FDA Approvals
New NDA/BLA approvals for NESHER PHARMS over the last two years — novel drugs only, excluding generics and label supplements.
NESHER PHARMS's Therapeutic Areas
NESHER PHARMS's approved drugs and pipeline span 2 therapeutic areas, led by Cardiovascular and Infectious Disease, across 0 biologic and 0 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
NESHER PHARMS's Top Competitors
NESHER PHARMS's closest competitors by therapeutic-area and drug-target overlap include Merck, Baxter, and Sanofi. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
NESHER PHARMS Pipeline Snapshot
Active clinical trials for NESHER PHARMS across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1980-10-17
- Latest
- 2022-02-25
- Applications
- 33